Cargando…

Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer

[Image: see text] Prostate cancer (PCa) is the second most common cause of cancer death among American men after lung cancer. Unfortunately, current therapies do not provide effective treatments for patients with advanced, metastatic, or hormone refractory disease. Therefore, we seek to generate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martin, Stacy E., Ganguly, Tanushree, Munske, Gerhard R., Fulton, Melody D., Hopkins, Mark R., Berkman, Clifford E., Black, Margaret E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198102/ https://www.ncbi.nlm.nih.gov/pubmed/25157916 http://dx.doi.org/10.1021/bc500362n

Ejemplares similares

Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
por: LIU, TIANCHENG, et al.
Publicado: (2012)

PDEPT: polymer-directed enzyme prodrug therapy
por: Satchi, R, et al.
Publicado: (2001)

Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
por: Denny, William A
Publicado: (2003)

Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on β-Glucosidase/Amygdalin
por: Zhou, Jie, et al.
Publicado: (2020)

Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy
por: Dachs, Gabi U., et al.
Publicado: (2009)

Microbial cytosine deaminase is a programmable anticancer prodrug mediating enzyme: antibody, and gene directed enzyme prodrug therapy
por: El-Sayed, Ashraf S.A., et al.
Publicado: (2022)

Fusion Enzymes Containing HSV-1 Thymidine Kinase Mutants and Guanylate Kinase Enhance Prodrug Sensitivity In Vitro and In Vivo
por: Ardiani, Andressa, et al.
Publicado: (2009)

Antibody directed enzymes revive anti-cancer prodrugs concept.
por: Bagshawe, K. D.
Publicado: (1987)

Pseudomonas aeruginosa NfsB and nitro-CBI-DEI – a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy
por: Green, Laura K, et al.
Publicado: (2013)

Use of horseradish peroxidase for gene-directed enzyme prodrug therapy with paracetamol
por: Tupper, J, et al.
Publicado: (2004)

Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy
por: Chis, Adriana Aurelia, et al.
Publicado: (2021)

Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells
por: LIU, TIANCHENG, et al.
Publicado: (2014)

Substrate Mediated Enzyme Prodrug Therapy
por: Fejerskov, Betina, et al.
Publicado: (2012)

Enzyme Models—From Catalysis to Prodrugs
por: Breijyeh, Zeinab, et al.
Publicado: (2021)

Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives
por: Roemhild, Karolin, et al.
Publicado: (2022)

Prolonged androgen deprivation leads to overexpression of calpain 2: Implications for prostate cancer progression
por: LIU, TIANCHENG, et al.
Publicado: (2013)

From AR to c-Met: Androgen deprivation leads to a signaling pathway switch in prostate cancer cells
por: LIU, TIANCHENG, et al.
Publicado: ( 201)

Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo
por: Theys, J, et al.
Publicado: (2006)

Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material
por: Webley, S D, et al.
Publicado: (2001)

The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy
por: Green, Laura K., et al.
Publicado: (2013)

Identification of activating enzymes of a novel FBPase inhibitor prodrug, CS-917
por: Kubota, Kazuishi, et al.
Publicado: (2015)

Prodrug converting enzyme gene delivery by L. monocytogenes
por: Stritzker, Jochen, et al.
Publicado: (2008)

Engineering Extracellular Vesicles with the Tools of Enzyme Prodrug Therapy
por: Fuhrmann, Gregor, et al.
Publicado: (2018)

Computational Simulations to Guide Enzyme-Mediated Prodrug Activation
por: Markovic, Milica, et al.
Publicado: (2020)

Polymeric Nanovectors Incorporated with Ganciclovir and HSV-tk Encoding Plasmid for Gene-Directed Enzyme Prodrug Therapy
por: Sawdon, Alicia J., et al.
Publicado: (2021)

Gene-Directed Enzyme Prodrug Therapy by Dendrimer-Like Mesoporous Silica Nanoparticles against Tumor Cells
por: Candela-Noguera, Vicente, et al.
Publicado: (2021)

Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme
por: Rajabi, Nima, et al.
Publicado: (2022)

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours
por: Francis, R J, et al.
Publicado: (2002)

Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy
por: Hagen, Sven, et al.
Publicado: (2014)

Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)
por: Monks, N R, et al.
Publicado: (2000)

Preparation of Enzyme-Activated Thapsigargin Prodrugs by Solid-Phase Synthesis
por: Zimmermann, Tomas, et al.
Publicado: (2018)

Enzyme-Catalyzed Kinetic Resolution of Chiral Precursors to Antiviral Prodrugs
por: Xiang, Dao Feng, et al.
Publicado: (2019)

Handbuch des Schutzgasschweissens: elektronische Grundlagen, Schweissanlagen, Einstellpraxis
por: Munske, H
Publicado: (1975)

Plasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo.
por: Rogers, G. T., et al.
Publicado: (1995)

Short communication: A33scFv–cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy
por: Deckert, P M, et al.
Publicado: (2003)

Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: comparison with experimental data.
por: Baxter, L. T., et al.
Publicado: (1996)

Characterization of a fusion protein of RGD4C and the β-lactamase variant for antibody-directed enzyme prodrug therapy
por: Zhou, Xiaoliang, et al.
Publicado: (2014)

In vitro studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapy
por: Al-mansoori, Layla, et al.
Publicado: (2020)

Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)
por: Mayer, A, et al.
Publicado: (2004)

Targeting assay of a fusion protein applied in enzyme prodrug therapy
por: Wang, Hao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q8u8oeci31f01gnjnvqriuvrkl